Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model.

Sanderlin EJ, Marie M, Velcicky J, Loetscher P, Yang LV.

Eur J Pharmacol. 2019 Jun 5;852:218-230. doi: 10.1016/j.ejphar.2019.03.038. Epub 2019 Mar 28.

PMID:
30930250
2.

Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report.

Naqash AR, Yang LV, Sanderlin EJ, Atwell DC, Walker PR.

Acta Oncol. 2018 May;57(5):705-708. doi: 10.1080/0284186X.2017.1406668. Epub 2017 Nov 24. No abstract available.

PMID:
29171332
3.

Contextual tumor suppressor function of T cell death-associated gene 8 (TDAG8) in hematological malignancies.

Justus CR, Sanderlin EJ, Dong L, Sun T, Chi JT, Lertpiriyapong K, Yang LV.

J Transl Med. 2017 Oct 10;15(1):204. doi: 10.1186/s12967-017-1305-6.

4.

GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis.

Sanderlin EJ, Leffler NR, Lertpiriyapong K, Cai Q, Hong H, Bakthavatchalu V, Fox JG, Oswald JZ, Justus CR, Krewson EA, O'Rourke D, Yang LV.

Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):569-584. doi: 10.1016/j.bbadis.2016.12.005. Epub 2016 Dec 7.

5.

Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment.

Justus CR, Sanderlin EJ, Yang LV.

Int J Mol Sci. 2015 May 15;16(5):11055-86. doi: 10.3390/ijms160511055. Review.

Supplemental Content

Loading ...
Support Center